The Conundrum of Intermediate Risk in Localised Prostate Cancer: One Group, Many Realities.

IF 9.3 1区医学 Q1 ONCOLOGY

European urology oncology Pub Date : 2025-10-11 DOI:10.1016/j.euo.2025.09.017

Arthur Peyrottes, Guillaume Ploussard, Paul Sargos, Eric Barret, Michael Baboudjian

引用次数: 0

Abstract

For intermediate-risk prostate cancer, definitions remain inconsistent and management varies. Greater precision is urgently needed via optimal use of existing tools and integration of emerging innovations to harmonise care and improve outcomes for this most common disease category.

查看原文本刊更多论文

局部前列腺癌的中间风险难题：一个群体，许多现实。

对于中危前列腺癌，定义仍然不一致，治疗方法也各不相同。迫切需要通过优化现有工具和整合新兴创新来提高精度，以协调这一最常见疾病类别的护理和改善结果。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

European urology oncology Multiple-

CiteScore

15.50

自引率

2.40%

发文量

128

审稿时长

20 days

期刊介绍： Journal Name: European Urology Oncology Affiliation: Official Journal of the European Association of Urology Focus: First official publication of the EAU fully devoted to the study of genitourinary malignancies Aims to deliver high-quality research Content: Includes original articles, opinion piece editorials, and invited reviews Covers clinical, basic, and translational research Publication Frequency: Six times a year in electronic format